Eyal Zohar, Matzov Donna, Krupkin Miri, Wekselman Itai, Paukner Susanne, Zimmerman Ella, Rozenberg Haim, Bashan Anat, Yonath Ada
Department of Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.
Nabriva Therapeutics AG, 1110 Vienna, Austria.
Proc Natl Acad Sci U S A. 2015 Oct 27;112(43):E5805-14. doi: 10.1073/pnas.1517952112. Epub 2015 Oct 13.
The emergence of bacterial multidrug resistance to antibiotics threatens to cause regression to the preantibiotic era. Here we present the crystal structure of the large ribosomal subunit from Staphylococcus aureus, a versatile Gram-positive aggressive pathogen, and its complexes with the known antibiotics linezolid and telithromycin, as well as with a new, highly potent pleuromutilin derivative, BC-3205. These crystal structures shed light on specific structural motifs of the S. aureus ribosome and the binding modes of the aforementioned antibiotics. Moreover, by analyzing the ribosome structure and comparing it with those of nonpathogenic bacterial models, we identified some unique internal and peripheral structural motifs that may be potential candidates for improving known antibiotics and for use in the design of selective antibiotic drugs against S. aureus.
细菌对抗生素的多重耐药性的出现,有可能使我们退回到抗生素出现之前的时代。在此,我们展示了来自金黄色葡萄球菌(一种多功能的革兰氏阳性侵袭性病原体)的大核糖体亚基的晶体结构,以及它与已知抗生素利奈唑胺和泰利霉素,以及与一种新型高效截短侧耳素衍生物BC - 3205形成的复合物的晶体结构。这些晶体结构揭示了金黄色葡萄球菌核糖体的特定结构基序以及上述抗生素的结合模式。此外,通过分析核糖体结构并将其与非致病性细菌模型的结构进行比较,我们确定了一些独特的内部和外围结构基序,这些基序可能是改进已知抗生素以及用于设计针对金黄色葡萄球菌的选择性抗生素药物的潜在候选对象。